Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
“Identifying these cells is important because this opens the door to designing specific therapeutic strategies to target or disable them."
The New York Times’ women’s health advice columnist says the claim is not true, no matter what your mother says.
A small study looked at response rates among those with HRAS-mutant head and neck carcinoma.
After finding a protein that smoking affects to drive head and neck cancer, investigators hope manipulating it will prove beneficial.
Between 1970 and 2009, melanoma rates increased nearly 10-fold among women under 40.
Singer-songwriter John Prine’s songs have embraced pain with kindness and a wicked and whimsical sense of humor.
The program proved as accurate as experienced pathologists at diagnosing adenocarcinomas and squamous cell carcinomas.
“The challenge now is to exploit this knowledge for therapeutics,” says researcher Joaquin Espinosa, PhD.
Cemiplimab is the first treatment for metastatic or locally advanced cutaneous squamous cell carcinoma.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.